Xuting Xu
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 14
- RNA modifications and cancer 3
- Oncology 10
- Saffron Plant Research Studies 3
- Co-authors
- Shiwei Duan (23 shared papers)Pingping Niu (5 shared papers)Zhaozheng Zheng (4 shared papers)Huadan Ye (12 shared papers)Jian Liu (2 shared papers)Yi Huang (8 shared papers)Guiyang Zhang (2 shared papers)Yan Chen (1 shared paper)
- Journals
- PLoS ONE (6 papers)Gene (2 papers)Frontiers in Genetics (1 paper)Cancer Medicine (1 paper)BMC Surgery (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xuting Xu
43 papers receiving 872 citations
Peers
Comparison fields: 5 of 104
- Biological Psychiatry 21
- Cancer Research 78
- Oncology 132
- Molecular Biology 361
- Genetics 108
Countries citing papers authored by Xuting Xu
This map shows the geographic impact of Xuting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuting Xu more than expected).
Fields of papers citing papers by Xuting Xu
This network shows the impact of papers produced by Xuting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuting Xu. The network helps show where Xuting Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuting Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 79 | |
| 2 | 2018 | 76 | |
| 3 | 2014 | 51 | |
| 4 | 2016 | 48 | |
| 5 | 2018 | 47 | |
| 6 | 2020 | 46 | |
| 7 | 2014 | 39 | |
| 8 | 2013 | 34 | |
| 9 | 2017 | 32 | |
| 10 | 2018 | 30 | |
| 11 | 2015 | 29 | |
| 12 | 2019 | 24 | |
| 13 | 2014 | 23 | |
| 14 | 2021 | 22 | |
| 15 | 2015 | 22 | |
| 16 | 2015 | 21 | |
| 17 | 2017 | 20 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2014 | 18 |
About Xuting Xu
Xuting Xu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 45 papers that have together received 879 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (14 papers), Cannabis and Cannabinoid Research (3 papers), Genetic factors in colorectal cancer (3 papers), Cancer Mechanisms and Therapy (3 papers), RNA modifications and cancer (3 papers), Saffron Plant Research Studies (3 papers), Birth, Development, and Health (3 papers) and Plant Molecular Biology Research (2 papers). The work is most often cited by research in Biological Psychiatry (21 citations), Cancer Research (78 citations), Oncology (132 citations), Molecular Biology (361 citations) and Genetics (108 citations). Xuting Xu has collaborated with scholars based in China and United States. Frequent co-authors include Shiwei Duan, Pingping Niu, Zhaozheng Zheng, Huadan Ye, Jian Liu, Yi Huang, Guiyang Zhang, Yan Chen, Jian Liu and Meng Ye. Their work appears in journals such as PLoS ONE, Gene, Frontiers in Genetics, Cancer Medicine and BMC Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.